Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats

Behavioural Brain Research

Volumn 189, Issue 1, 2008, Pages 191-201

  Kurling, Sanna ^a   Kankaanpää, Aino ^a   Seppälä, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

5 HT; Amphetamine; Anabolic steroids; Dopamine; MDMA; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE; ANABOLIC AGENT; ANDROGEN; DOPAMINE; HOMOVANILLIC ACID; NANDROLONE DECANOATE; PSYCHOTROPIC AGENT; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPING; DRUG ABUSE; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; VIDEOTAPE;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; ANABOLIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NANDROLONE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REWARD; SEROTONIN; STATISTICS, NONPARAMETRIC;

EID: 40849095831     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.12.021     Document Type: Article

References (52)

1. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res 892 2 (2001) 255-262
2. Arvary D., and Pope H.G. Anabolic-androgenic steroids as a gateway to opioid dependence. N Engl J Med 342 20 (2000) 1532
3. Bahrke M.S., Yesalis C.E., Kopstein A.N., and Stephens J.A. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med 29 6 (2000) 397-405
4. Baselt R. Disposition of toxic drugs and chemicals in man. 7th ed. (2004), Biomedical Publications, Foster City, California p. 1254
5. Beatty W.W., Dodge A.M., and Traylor K.L. Stereotyped behavior elicited by amphetamine in the rat: influences of the testes. Pharmacol Biochem Behav 16 4 (1982) 565-568
6. Birgner C., Kindlundh-Hogberg A.M., Nyberg F., and Bergstrom L. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge. Neurosci Lett 412 2 (2007) 168-172
7. Bitar M.S., Ota M., Linnoila M., and Shapiro B.H. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology 16 6 (1991) 547-557
8. Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E., and Di Chiara G. Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core. Brain Res 1055 1-2 (2005) 143-148
9. Celerier E., Ahdepil T., Wikander H., Berrendero F., Nyberg F., and Maldonado R. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence. Neuropharmacology 50 7 (2006) 788-806
10. Celerier E., Yazdi M.T., Castane A., Ghozland S., Nyberg F., and Maldonado R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur J Pharmacol 465 1-2 (2003) 69-81
11. Chin J., Sternin O., Wu H.B., Burrell S., Lu D., Jenab S., et al. Endogenous gonadal hormones modulate behavioral and neurochemical responses to acute and chronic cocaine administration. Brain Res 945 1 (2002) 123-130
12. Chu T., Kumagai Y., DiStefano E.W., and Cho A.K. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51 6 (1996) 789-796
13. Clark A.S., Lindenfeld R.C., and Gibbons C.H. Anabolic-androgenic steroids and brain reward. Pharmacol Biochem Behav 53 3 (1996) 741-745
14. Creese I., and Iversen S.D. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia 39 4 (1974) 345-357
15. Dare E., Gotz M.E., Zhivotovsky B., Manzo L., and Ceccatelli S. Antioxidants J811 and 17beta-estradiol protect cerebellar granule cells from methylmercury-induced apoptotic cell death. J Neurosci Res 62 4 (2000) 557-565
16. Dluzen D.E., Green M.A., and Ramirez V.D. The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat. Horm Behav 20 1 (1986) 1-6
17. Du J., and Hull E.M. Effects of testosterone on neuronal nitric oxide synthase and tyrosine hydroxylase. Brain Res 836 1-2 (1999) 90-98
18. DuRant R.H., Escobedo L.G., and Heath G.W. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 96 1 Pt 1 (1995) 23-28
19. Estrada M., Varshney A., and Ehrlich B.E. Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem 281 35 (2006) 25492-25501
20. Fleckenstein A.E., and Hanson G.R. Impact of psychostimulants on vesicular monoamine transporter function. Eur J Pharmacol 479 1-3 (2003) 283-289
21. Fudala P.J., Weinrieb R.M., Calarco J.S., Kampman K.M., and Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry 15 2 (2003) 121-130
22. Garcia de Yebenes E., Hong M., and Pelletier G. Effects of dehydroepiandrosterone (DHEA) on pituitary prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat. J Neuroendocrinol 7 8 (1995) 589-595
23. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA "ecstasy"). Pharmacol Rev 55 3 (2003) 463-508
24. Harlan R.E., Brown H.E., Lynch C.S., D'Souza D., and Garcia M.M. Androgenic-anabolic steroids blunt morphine-induced c-fos expression in the rat striatum: possible role of beta-endorphin. Brain Res 853 1 (2000) 99-104
25. Kankaanpaa A., Ellermaa S., Meririnne E., Hirsjarvi P., and Seppala T. Acute neurochemical and behavioral effects of stereoisomers of 4-methylaminorex in relation to brain drug concentrations. J Pharmacol Exp Ther 300 2 (2002) 450-459
26. Kankaanpaa A., Gunnar T., Ariniemi K., Lillsunde P., Mykkanen S., and Seppala T. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 810 1 (2004) 57-68
27. Kankaanpaa A., Meririnne E., Ariniemi K., and Seppala T. Oxalic acid stabilizes dopamine, serotonin, and their metabolites in automated liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 753 2 (2001) 413-419
28. Kindlundh A.M., Bergstrom M., Monazzam A., Hallberg M., Blomqvist G., Langstrom B., et al. Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography. Prog Neuropsychopharmacol Biol Psychiatry 26 7-8 (2002) 1303-1308
29. Kindlundh A.M., Hagekull B., Isacson D.G., and Nyberg F. Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health 11 3 (2001) 322-328
30. Kindlundh A.M., Isacson D.G., Berglund L., and Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 94 4 (1999) 543-553
31. Kindlundh A.M., Lindblom J., and Nyberg F. Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain. Brain Res 979 1-2 (2003) 37-42
32. Kindlundh A.M., Rahman S., Lindblom J., and Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci Lett 356 2 (2004) 131-134
33. Kizer J.S., Palkovits M., Kopin I.J., Saavedra J.M., and Brownstein M.J. Lack of effect of various endocrine manipulations on tryptophan hydroxylase activity of individual nuclei of the hypothalamus, limbic system, and midbrain of the rat. Endocrinology 98 3 (1976) 743-747
34. Kurling S., Kankaanpaa A., Ellermaa S., Karila T., and Seppala T. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats. Brain Res 1044 1 (2005) 67-75
35. Le Greves P., Zhou Q., Huang W., and Nyberg F. Effect of combined treatment with nandrolone and cocaine on the NMDA receptor gene expression in the rat nucleus accumbens and periaqueductal gray. Acta Psychiatr Scand Suppl 412 (2002) 129-132
36. Masonis A.E., and McCarthy M.P. Direct effects of the anabolic/androgenic steroids, stanozolol and 17 alpha-methyltestosterone, on benzodiazepine binding to the. gamma-aminobutyric acid(a) receptor. Neurosci Lett 189 1 (1995) 35-38
37. Mcallister S, Compton D. Cocaine-ondiced locomotion: modification by acute or chronic anabolic-androgenic steroid treatment. Scottsdale, AZ; 1995.
38. Mehta A.K., and Ticku M.K. Unsulfated and sulfated neurosteroids differentially modulate the binding characteristics of various radioligands of GABA(A) receptors following chronic ethanol administration. Neuropharmacology 40 5 (2001) 668-675
39. Morton J. Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol 5 1 (2005) 79-86
40. Nilsson S., Baigi A., Marklund B., and Fridlund B. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur J Public Health 11 2 (2001) 195-197
41. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8 8 (1988) 2788-2803
42. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Press A, San Diego
43. Rehavi M., Goldin M., Roz N., and Weizman A. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones. Brain Res Mol Brain Res 57 1 (1998) 31-37
44. Ricaurte G.A., Markowska A.L., Wenk G.L., Hatzidimitriou G., Wlos J., and Olton D.S. 3,4-Methylenedioxymethamphetamine, serotonin and memory. J Pharmacol Exp Ther 266 2 (1993) 1097-1105
45. Rupp A., Kovar K.A., Beuerle G., Ruf C., and Folkers G. A new pharmophoric model for 5-HT reuptake-inhibitors: differentiation of amphetamine analogues. Pharm Acta Helv 68 4 (1994) 235-244
46. Savageau M.M., and Beatty W.W. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats. Pharmacol Biochem Behav 14 1 (1981) 17-21
47. Schmidt C.J., Levin J.A., and Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36 5 (1987) 747-755
48. Stumpf W.E., and Sar M. Steroid hormone target sites in the brain: the differential distribution of estrogin, progestin, androgen and glucocorticosteroid. J Steroid Biochem 7 11-12 (1976) 1163-1170
49. Sturgeon R.D., Fessler R.G., and Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59 3-4 (1979) 169-179
50. Thiblin I., Finn A., Ross S.B., and Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic-androgenic steroids. Br J Pharmacol 126 6 (1999) 1301-1306
51. Vermes I., Varszegi M., Toth E.K., and Telegdy G. Action of androgenic steroids on brain neurotransmitters in rats. Neuroendocrinology 28 6 (1979) 386-393
52. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 94 4 (1987) 469-492